Abstract
Pseudomonas Aeruginosa is a common and opportunistic
pathogen that produces serious infections to patients with low immune system,
pneumonia, cystic fibrosis, blood conditions, and to people after surgery.
Furthermore, healthy individuals can also develop mild illnesses from these
pathogenic strains. These bacteria are associated with severe adverse outcomes
if treated with inappropriate initial antibiotic therapy, hence the need of an
accelerated technique for accurate and early detection that is noninvasive to
the patient. Several testing methods exist to detect the presence of the
Pseudomonas Aeruginosa. However, those techniques are invasive, costly, time
consuming, need specialized labs, and highly trained personnel. An innovative
technique being investigated at FIU allows for a noninvasive sampling of
signature volatiles in the patients’ breath that can potentially provide a
fast, accurate and painless medical diagnosis tool. The highlight of this
invention is the rapid sampling that can be coupled to commercially available
analytical instruments. The samples can be easily collected in the doctor’s office,
clinics, and hospitals and coupled to analytical instruments already available
in a lab for the comprehensive detection process.
Benefit
Noninvasive samplingFast, simple, and produce reliable resultsRequires an inexpensive device that is easily coupled to existing analytical instruments for detection
Market Application
Rapid, in-office test for the presence of PA
Brochure
